Antonio Nagel-Gil

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 135 publications

Efficacy and safety of fenfluramine in Dravet syndrome: The impact of patient clinical characteristics.

Efficacy and safety of fenfluramine in Dravet syndrome: The impact of patient clinical characteristics.

Journal: Epilepsia open
Published: June 08, 2026

Facilitating the timely diagnosis of Lennox-Gastaut syndrome: A checklist to support clinical practice.

Facilitating the timely diagnosis of Lennox-Gastaut syndrome: A checklist to support clinical practice.

Journal: Epileptic disorders : international epilepsy journal with videotape
Published: April 08, 2026

Changes in effectiveness and safety in patients with Lennox-Gastaut syndrome transitioning from the fenfluramine randomized controlled trial to open-label extension study.

Changes in effectiveness and safety in patients with Lennox-Gastaut syndrome transitioning from the fenfluramine randomized controlled trial to open-label extension study.

Journal: Epilepsia open
Published: April 01, 2026

Prolonged fenfluramine use in open-label studies of Dravet or Lennox-Gastaut syndromes: Long-term safety, tolerability, patient global functioning, and considerations for interpreting effectiveness.

Prolonged fenfluramine use in open-label studies of Dravet or Lennox-Gastaut syndromes: Long-term safety, tolerability, patient global functioning, and considerations for interpreting effectiveness.

Journal: Epilepsia
Published: March 13, 2026

Practical Recommendations for Cardiology Follow-Up in Patients Treated with Fenfluramine Based on Expert Opinion and Clinical Experience.

Practical Recommendations for Cardiology Follow-Up in Patients Treated with Fenfluramine Based on Expert Opinion and Clinical Experience.

Journal: Neurology and therapy
Published: February 13, 2026

Human hippocampal ripples tune cortical responses based on predicted uncertainty.

Human hippocampal ripples tune cortical responses based on predicted uncertainty.

Journal: Nature neuroscience
Published: February 11, 2026

Seizure-free days as a clinical outcome measure of reduced epilepsy burden: 5-year outcomes with cenobamate treatment.

Seizure-free days as a clinical outcome measure of reduced epilepsy burden: 5-year outcomes with cenobamate treatment.

Journal: Epilepsy & behavior : E&B
Published: December 19, 2025

Effect of Concomitant Medications on Adverse Event Frequency, Severity, and Time to Resolution in a Cenobamate Open-Label Trial.

Effect of Concomitant Medications on Adverse Event Frequency, Severity, and Time to Resolution in a Cenobamate Open-Label Trial.

Journal: European journal of neurology
Published: December 19, 2025

Teaching Video NeuroImage: Tapping-Triggered Seizure Secondary to Focal Cortical Dysplasia in the Primary Somatosensory Cortex.

Teaching Video NeuroImage: Tapping-Triggered Seizure Secondary to Focal Cortical Dysplasia in the Primary Somatosensory Cortex.

Journal: Neurology
Published: December 10, 2025

Lennox-Gastaut syndrome unveiled: Advancing diagnosis, therapies, and advocacy-insights from the Genoa International Workshop.

Lennox-Gastaut syndrome unveiled: Advancing diagnosis, therapies, and advocacy-insights from the Genoa International Workshop.

Journal: Epilepsia
Published: July 25, 2025

Fenfluramine for developmental and epileptic encephalopathy with spike-wave activation in sleep (DEE-SWAS): An exploratory study.

Fenfluramine for developmental and epileptic encephalopathy with spike-wave activation in sleep (DEE-SWAS): An exploratory study.

Journal: Epilepsy research
Published: July 18, 2025

Genotype-Phenotype Landscape of NALCN and UNC80-Related Disorders.

Genotype-Phenotype Landscape of NALCN and UNC80-Related Disorders.

Journal: Neurology
Published: March 06, 2025
Showing 1-12 of 135

Last Updated: 09/26/2026